[go: up one dir, main page]

DE735560C - Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds - Google Patents

Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds

Info

Publication number
DE735560C
DE735560C DESCH113623D DESC113623D DE735560C DE 735560 C DE735560 C DE 735560C DE SCH113623 D DESCH113623 D DE SCH113623D DE SC113623 D DESC113623 D DE SC113623D DE 735560 C DE735560 C DE 735560C
Authority
DE
Germany
Prior art keywords
water
diaminodiphenylsulfone
soluble
compounds
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DESCH113623D
Other languages
German (de)
Inventor
Dr Rudolf Tschesche
Dr Kurt Bohle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DESCH113623D priority Critical patent/DE735560C/en
Application granted granted Critical
Publication of DE735560C publication Critical patent/DE735560C/en
Expired legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Verfahren zur Herstellung wasserlöslicher 4, 4'-Diaminodiphenylsulfonverbindungen Es ist bekannt, daß das ¢, 4'-Diaminodiphexiylsulfon, dessen Herstellung auf verschiedenen Wegen möglich ist, sowie seine Diacetylverbindung zwar Präparate von hoher Wirksamkeit gegen Kokkeninfektionen, wie sie durch Streptokokken, Pneumokokken usw. hervorgerufen werden, darstellen, daß aber ein großer Nachteil für ihre Verwendung in ihrer Wasserunlöslichkeit liegt.Process for the preparation of water-soluble 4,4'-diaminodiphenylsulfone compounds It is known that [, 4'-diaminodiphexiylsulfone, its preparation on various Because it is possible, as well as its diacetyl compound, preparations of high effectiveness against cocci infections such as those caused by streptococci, pneumococci, etc. are, but represent a major disadvantage for their use in their water insolubility lies.

Es wurde nun gefunden, daß man zu wasserlöslichen Verbindungen des 4, 4'-Diaminodiphenylsulfons gelangen kann, wenn man 4, 4'-Diaminodiphenylsulfon mit Mono-oder Polysacchariden, die eine Aldehyd- bzw. Halbacetalgruppe enthalten, insbesondere Pentosen und Hexosen, wie Rhamnose, Glucose, Axabinos,e, Maltose, kondensiert. Die Kondensation wird zweckmäßig in alkoholischer Lösung bei erhöhter Temperatur; gegebenenfalls unter Anwendung eines Kondensationsmittels, wie z. B. Ammoniumchlorid, ausgeführt. Die so erhaltenen Kondensationsprodukte weisen die therapeutische Wirksamkeit des Ausgangsstoffes in vielfach erhöhtem Maße auf; außerdem ist deren Applikationsart nicht nur auf die perorale, wie beim Ausgangsstoff, beschränkt.It has now been found that water-soluble compounds of the 4, 4'-Diaminodiphenylsulfons can get, if one 4, 4'-Diaminodiphenylsulfon with mono- or polysaccharides that contain an aldehyde or hemiacetal group, in particular pentoses and hexoses, such as rhamnose, glucose, axabinos, e, maltose, condensed. The condensation is expediently carried out in alcoholic solution at an elevated temperature; optionally using a condensing agent, such as. B. ammonium chloride, executed. The condensation products thus obtained show the therapeutic effectiveness of the starting material to a much greater extent; also its type of application not only limited to the oral, as with the starting material.

Nachstehend seien Beispiele für die Herstellung der neuen Verbindungen gegeben, ohne jedoch die Herstellungsmöglichkeiten auf diese zu beschränken.The following are examples of the preparation of the new compounds given, but without restricting the manufacturing options to this.

Beispiel i i Mol 4, 4'-Diaminodiphenylsulfon werden mit 6 Mol Rhamnosie in Alkohol 4 Stunden am Rückflußkühler gekocht und der Alkohol dann im Vakuum abdestilliert. Das als Rückstand hinterbleibende braune öl, welches allenfalls noch weiter gereinigt werden kann, stellt das 4, 4'-Diaminodiph.enylsulfonrhamnosid dar. Es ist in Wasser sehr leicht löslich und besitzt etwa zehnmal so starke Wir, kung auf die Streptokokkeninfektion wie das -wasserunlösliche 4., 4'-Diaminodiphenylsulfon. Beispiel 2 4- 4"1'-Diaminodiphenylsulfon werden mit 12- Glucose und r g Ammoniumchlorid in Zoo cmj Alkohol 3i,'2 Stunden auf dem Wasserbad erhitzt. Die Lösung wird im Vakuum eingeengt und das 4, 4'-Diaminodiphenylsulfonglucosid als in Wasser leicht lösliches öl erhalten. Es zeigt ungefähr die gleiche Wirkung auf die Streptakokheninfektion wie das Rhamnosid.Example i i moles of 4,4'-diaminodiphenyl sulfone are with 6 moles of rhamnosie Boiled in alcohol for 4 hours on a reflux condenser and the alcohol then distilled off in vacuo. The brown oil that remains as a residue, which at most which can be purified even further is the 4,4'-diaminodiph.enylsulfonrhamnosid It is very easily soluble in water and has about ten times as strong a we, effect on streptococcal infection such as the water-insoluble 4, 4'-diaminodiphenyl sulfone. Example 2 4- 4 "1'-diaminodiphenylsulfone are made with 12-glucose and r g ammonium chloride in zoo cmj alcohol 3i, 'heated on a water bath for 2 hours. The solution is in vacuo concentrated and the 4, 4'-diaminodiphenylsulfonglucoside as easily soluble in water get oil. It shows roughly the same effect on strep throat infection like the rhamnoside.

Beispiel 3 i Mol 4, 4'-Diaminodiphenylsulfon werden mit 6 Mol Arabinose in Alkohol 4. Stunden am Kühler gekocht und der Alkohol dann im Vakuum abdestilliiert. Das als Rückstand hinterbliebene hellbraun gefärbte Öl, welches allenfalls noch weiter gereinigt werdenkann, stellt das 4, 4'-Diaminodiphenylsulfonarabinosid dar. ES ist in Wasser leicht löslich und zeigt die gleichen physiologischen Eigenschaften wie das Glucosid.Example 3 i moles of 4,4'-diaminodiphenyl sulfone are mixed with 6 moles of arabinose Boiled in alcohol on a condenser for 4 hours and then distilled off the alcohol in vacuo. The light brown oil left behind as residue, which at most is still which can be further purified is the 4,4'-diaminodiphenylsulfonarabinoside. ES is easily soluble in water and shows the same physiological properties like the glucoside.

Beispiel q.Example q.

5 g 4, 4'-Diaminodiphenylsulfon werden mit 459 Maltose, o,5 g Ammoniumchlorid und 25o cm2 Methanol mehrere Stunden auf dem Wasserbade zum Sieden erhitzt. Danach werden 2o cma Wasser hinzugefügt und das Methanol auf dem Wasserbade abgetrieben. Es hinterbleibt das 4, 4'-Diaminodiphenylsulfonmaltosid als gelb gefärbter dicker Sirup, der sich leicht in Wasser auflöst.5 g of 4,4'-diaminodiphenyl sulfone are mixed with 459 maltose, 0.5 g of ammonium chloride and 250 cm2 of methanol are heated to boiling on the water bath for several hours. Thereafter 2o cma water are added and the methanol is driven off on the water bath. The 4,4'-diaminodiphenylsulfone maltoside remains behind as a thicker yellow color Syrup that dissolves easily in water.

Durch Toxizitätsversuche an Mäusen wurde festgestellt, daß 2omg dieser neuen Präparate von der Maus vertragen werden, während bereits 5 mg 4, 4'-Diaminodiphenylsulfon toxisch wirken.Toxicity tests on mice found that 2omg of this new preparations are tolerated by the mouse while already 5 mg of 4, 4'-diaminodiphenyl sulfone have a toxic effect.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung wasserlöslicher 4, 4'=Diaminodiphenylsulfonverbindungen, dadurch gekennzeichnet, daß man 4, 4'-Diaminodiphenylsulfon mit Mono-oder Polysacchariden, die eine Aldehyd-bzw. Halbacetalgruppe enthalten, kondensiert. Claim: Process for the production of water-soluble 4, 4 '= diaminodiphenylsulfone compounds, characterized in that 4, 4'-diaminodiphenylsulfone with mono- or polysaccharides, which are an aldehyde or. Containing hemiacetal group, condensed.
DESCH113623D 1937-08-21 1937-08-21 Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds Expired DE735560C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DESCH113623D DE735560C (en) 1937-08-21 1937-08-21 Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH113623D DE735560C (en) 1937-08-21 1937-08-21 Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds

Publications (1)

Publication Number Publication Date
DE735560C true DE735560C (en) 1943-05-18

Family

ID=7449927

Family Applications (1)

Application Number Title Priority Date Filing Date
DESCH113623D Expired DE735560C (en) 1937-08-21 1937-08-21 Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds

Country Status (1)

Country Link
DE (1) DE735560C (en)

Similar Documents

Publication Publication Date Title
DE2422254A1 (en) AMINOGLYCOSIDE DERIVATIVES AND THEIR SALTS, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS
DE735560C (en) Process for the preparation of water-soluble 4,4-diaminodiphenylsulfone compounds
DE3820588A1 (en) 2 ', 3'-DIDESOXY-4-THIOURIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND ANTIVIRUS AGENTS CONTAINING THEM
DE2942818A1 (en) NEW ANTITUMORANTHRACYCLINE WITH A CONTENT OF BRANCHED CHAIN AMINODEOXY SUGARS AND METHOD FOR THE PRODUCTION THEREOF
DE2357864A1 (en) Anti-diabetic agents prepn. - from biguanidine (salt) and nicotinic acid (salt)
DE1282852B (en) Orally applicable medicinal product containing aescin
DE1793694C3 (en) Helveticoside derivatives
DE665511C (en) Process for the preparation of the active ingredient of calebasse curare in crystallized, pure form
DE810027C (en) Process for the production of a novel Abkoemmlings des ‡ -Phenylaethylalkohols
DE545917C (en) Process for the preparation of condensation products of amino-substituted arsenic compounds
DE495336C (en) Process for the preparation of basic oxime ethers and their salts
DE752680C (en) Anion exchange
DE2307795C3 (en) 11 beta 17alpha, 21 trihydroxy-6
AT113002B (en) Process for the preparation of monoboric acid choline.
DE2436479A1 (en) METHOD OF CLEANING UP STEROID HETEROSIDES
DE1793686C3 (en) Helveticoside derivatives and medicinal products containing them
DE646706C (en) Process for the preparation of substituted 6, 7-dioxy-1, 2, 3, 4-tetrahydroisoquinoline-1-carboxylic acids
DE2542708A1 (en) N-SUBSTITUTED IMINODIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR USE
DE491573C (en) Process for obtaining durable filicin solutions
AT139605B (en) Process for the partial degradation of digitalis glucosides.
AT146635B (en) Process for the preparation of compounds of dihydrocodeine, which are readily soluble in water, with alkylated barbituric acids.
DE2015076C3 (en) Antibiotic known as Tolypomycin RB (B-2847 RB) and the process for making it
DE220267C (en)
DE87099C (en)
AT325783B (en) PROCESS FOR SEPARATING THE GLYCOFRANGULIN COMPLEX FROM VEGETABLE RAW MATERIALS, IN PARTICULAR FROM THE DRIED BARK OF THE ROTARY TREE